Author

A. Barkhymer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:rat· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. M. Weiler· 1 shared A. Richardon· 1 shared A. S. Jaeger· 1 shared B. Taye· 1 shared Boyd Rasmussen and Frank J. Secreto, Timothy J. Nelson (Director)· 1 shared C. K. Navaratnarajah· 1 shared C. M. Crooks· 1 shared D. R. Pease· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. M. Weiler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Primary infection with Zika virus provides one-way heterologous protection against Spondweni virus infection in rhesus macaques

A. S. Jaeger, C. M. Crooks, A. M. Weiler, M. I. Bliss, S. L. Rybarczyk, A. Richardon, M. Einwalter, E. Peterson, S. Capuano, A. Barkhymer, J. T. Becker, J. T. Greene, T. S. Freedman, R. A. Langlois, T. C. Friedrich, M. T. Aliota

This study shows that ZIKV infection protects against SPONV in rhesus macaques, but not vice versa, suggesting one-way cross-protection between the viruses.

bioRxiv · Dec 16, 2022Microbiology

Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition

C. K. Navaratnarajah, D. R. Pease, P. Halfmann, B. Taye, A. Barkhymer, K. G. Howell, J. E. Charlesworth, T. A. Christensen, Y. Kawaoka, R. Cattaneo, J. W. Schneider, Boyd Rasmussen and Frank J. Secreto, Timothy J. Nelson (Director)

This paper shows SARS-CoV-2 efficiently infects human cardiomyocytes via spike protein-mediated fusion, which is inhibited by furin blockade.

bioRxiv · Jul 30, 2021Microbiology